Michael Lewis

Michael Lewis is a declared insider of Ocugen, Inc., with filings sourced from SEC (Form 4). We count 12 filings; the first trade dates from 8 December 2014 and the latest from 8 February 2019.

Market trades split into 2 purchases (€3.5M) and 1 sale (€7,086). The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants and 2 option exercises.

Most recently, on 11 February 2019, the filings show an option exercise in Ocugen, Inc. The last insider purchase was made public on 11 October 2018, 2,951 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.